Battle against TB
Latest WHO report highlights the advances made by countries in controlling the spread of tuberculosis and recommends ways to achieve eradication
The fine line for judges
Judges have recused themselves in a number of cases but there are no clear guidelines on what constitutes conflict of interest
Get your own vaccine
Down To Earth filed an RTI application to find out the reason of vaccine shortage in India. The response revealed how a plan to promote private …
NCD battle starts now
The UN agreement on non-communicable diseases will get snagged on the issue of intellectual property rights for drugs
Maths of Gilead's hepatitis C drug
Why US firm's super expensive drug sofosbuvir costs so much and how it can be made at a tenth of current price
Drug pricing policies bent to favour pharma industry, allege health experts
Nearly 83 per cent medicines out of the ambit of price control policy, thus making them out of reach for most patients, say two recent reports
Cipla's bitter pill for MNCs
Several eyebrows have been raised over the Cipla offer to supply anti- aids drugs at one-third the current price to developing countries like …
Obama takes first dip
The US becomes the first to join a global patents pool to make AIDS drugs cheaper but health workers are sceptical of the initiative
Blood from Ebola survivors should be used to treat disease: WHO
Antibodies from the blood of patients who have recovered could be transferred to those who are suffering from the viral disease
Drug trials: SC pulls up Centre for not compensating victims who suffered severe adverse effects
Asks government to pay victims and recover the money from pharma companies sponsoring the drug trials later
European Parliament rejects Anti-Counterfeiting Trade Agreement
Act makes it possible to seize and destroy even legitimately produced generic drugs exported from India to poor countries
Scientists identify genes that help TB bug survive
The new findings may lead to the development of more effective drugs and vaccine against tuberculosis
Cipla's audacious move
Why generics maker Cipla has asked government to revoke Novartis patent on respiratory ailment drug
US keeps India out of Priority Foreign Country list of 'worst IP offenders'
US Trade Representative’s Special 301 Report keeps up pressure on India to fall in line with US’ interests
The natco-pfizer test
Natco’s demand for a voluntary licence from Pfizer will establish how well the compulsory licence process works in India
Phase-II trials for new clot buster drug approved
Bio-therapeutic drug, Clot Specific Streptokinase, meant for patients who suffer heat attack, was developed using bacteria
Choking access to drugs
Drug prices are likely to increase as rich countries and their pharma companies squeeze Indian generics out of the market. How can India’s …
Any cheers for Doha pact?
The Doha Declaration on protecting public health is a decade old, but developing countries have not been able to make use of TRIPs flexibilities
Drug affordability test
Natco’s bid for a compulsory licence to manufacture a Bayer anti-cancer drug is a test of the law’s ‘reasonable price’ …
Supreme Court issues notice to Centre on HPV vaccines for cervical cancer
Gardasil and Cervarix were approved by drugs controller even though they are unproven and hazardous, alleges petition
DTE Exclusive: Govt report blames half of Gir lion deaths in January-May this year on diseases
The other half died of natural causes, snake bite, electrocution and by falling into wells
When flu turns fatal
In the past two months, as many as 1,198 people in India have died of swine flu, a disease which is only as threatening as seasonal flu. Jyotsna …
7,500 child TB patients go untreated in Madhya Pradesh
Paediatric TB drugs in short supply; norms forbid purchase of medicines from non-government sources
Is that milk safe? CSE’s assessment of antibiotic misuse in dairy sector says it’s not
A recent assessment found that dairy farmers indiscriminately use antibiotics for diseases common in animals, and is likely to aggravate the …
Predatory EU pacts
EU is pushing India and Canada to sign free trade agreements that will hurt their generic drugs—and the outrage is global